BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31028202)

  • 41. Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.
    Dionysopoulos D; Pavlakis K; Kotoula V; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Nikolaou A; Kalogeras KT; Fountzilas G
    Strahlenther Onkol; 2013 Mar; 189(3):202-14. PubMed ID: 23400686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent appearance of club cell (Clara cell)-like cells as a histological marker for ALK-positive lung adenocarcinoma.
    Miyata-Morita K; Morita S; Matsutani N; Kondo F; Soejima Y; Sawabe M
    Pathol Int; 2019 Dec; 69(12):688-696. PubMed ID: 31625265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series.
    Shin HJ; Kho BG; Kim MS; Park HY; Kim TO; Kim YI; Lim SC; Park CK; Kim YC; Choi YD; Oh IJ
    Medicine (Baltimore); 2019 Mar; 98(9):e14699. PubMed ID: 30817606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.
    Wang X; Chen S; Emerson RE; Wu HH; Cramer HM; Curless K; Chang HY; Zhang S; Randolph ML; Cheng L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):119-124. PubMed ID: 30688675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation.
    Zhang B; Zeng J; Zhang H; Zhu S; Wang H; He J; Yang L; Zhou N; Zu L; Xu X; Song Z; Xu S
    Front Immunol; 2022; 13():974581. PubMed ID: 36159860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis.
    Chrysovergis A; Papanikolaou V; Tsiambas E; Stavraka C; Ragos V; Peschos D; Psyrri A; Mastronikolis N; Kyrodimos E
    Anticancer Res; 2019 Aug; 39(8):4137-4142. PubMed ID: 31366498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of integrin-linked kinase is closely correlated with laryngeal squamous cell carcinomas].
    Wu C; Zhai N; Guan C; Ji W
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(9):393-5. PubMed ID: 16836071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
    Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical expression of p27(kip1) in metastatic laryngeal squamous cell carcinoma.
    Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
    Adv Med Sci; 2014 Sep; 59(2):206-12. PubMed ID: 25323759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
    Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
    Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical significance of Stat3 and Cyclin D1 expression in laryngeal squamous cell carcinoma].
    Wang L; Duan X; Tang X; Shao Y; Zhao R; Qian X; Gao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 25(21):966-9. PubMed ID: 22260073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance].
    Chen Y; He Y; Zhang S; Li L; Zhu X; Liu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 23(12):539-41, 545. PubMed ID: 19771908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma.
    Zou Y; Fang F; Ding YJ; Dai MY; Yi X; Chen C; Tao ZZ; Chen SM
    Mol Med Rep; 2016 Oct; 14(4):3517-24. PubMed ID: 27572051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of c-myc oncoprotein in laryngeal squamous cell carcinoma.
    Krecicki T; Fraczek M; Jelen M; Zatonski T; Szkudlarek T; Dus D
    Acta Otolaryngol; 2004 Jun; 124(5):634-7. PubMed ID: 15267185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas.
    Cao XL; Xu RJ; Zheng YY; Liu J; Teng YS; Li Y; Zhu J
    Asian Pac J Cancer Prev; 2011; 12(12):3245-9. PubMed ID: 22471461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis.
    Li F; Liu Y; Kan X; Li Y; Liu M; Lu JG
    Pathol Res Pract; 2013 Feb; 209(2):105-9. PubMed ID: 23261238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
    Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
    PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.